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Introduction
Thousands of neurons are created every day in the subventricular
zone (SVZ) of postnatal and adult mammalian brains (Petreanu
and Alvarez-Buylla, 2002). In the SVZ, slowly proliferating
astrocytes expressing glial fibrillary acidic protein (GFAP) give
rise to rapidly dividing immature precursors that generate
doublecortin (Dcx)-expressing neuroblasts. These neuroblasts
migrate along a well-defined route: the rostral migratory stream
(RMS) toward the olfactory bulb, where they differentiate into
granular and periglomerular interneurons (Luskin, 1993). They
advance in longitudinal chains, and are surrounded by astrocytic
glial tubes (Peretto et al., 1997).
The SVZ and RMS contain a specialized molecular niche that
promotes neurogenesis and migration. One of the niche factors
with an important role in both proliferation and migration is post-
translational glycosylation. Indeed, addition of polysialic acids to
the neural cell adhesion molecule is crucial for SVZ cell motility
(Ono et al., 1994). A complex mixture of proteins and carbohydrates
regulates adhesion of the cells to the extracellular matrix (ECM).
In addition, many proteins that are influential in SVZ migration,
such as the epidermal growth factor receptor (EGFR), integrins,
laminin and tenascin, are glycosylated (Kariya and Gu, 2009;
Woodworth et al., 2004). However, much remains unclear about
how these glycoconjugates and the molecules that mediate
interactions between them regulate SVZ migration.
Galectins are a family of proteins (Gal-1 to Gal-15) identified
by their similar carbohydrate recognition domains (CRDs), with a
conserved sequence of approximately 130 amino acids that binds
to galactoside residues. There are three different types of galectins,
the proto-galectins which contain a single CRD and which can
form homodimers, a chimeric galectin, characterized by a single
CRD and a large N-terminal domain that contributes to self-
aggregation, and the tandem-repeat galectins in which two CRDs
occur within a single polypeptide and are bridged by a small
peptide domain (Barondes et al., 1994; Hirabayashi and Kasai,
1993). Galectins regulate migration, cell–ECM adhesion, and cell
survival depending on their intra- or extracellular localization
(Elola et al., 2007). They have important actions in inflammation
and cancer, but their potential functions in brain development and
pathology are only now being revealed. It was recently discovered
that Galectin-1 increases SVZ neurogenesis and improves recovery
after stroke (Ishibashi et al., 2007; Sakaguchi et al., 2006), but the
expression and function of other galectins in the SVZ is unknown.
Galectin-3 (Gal-3) is uniquely chimeric amongst galectins and
has multiple roles (Delacour et al., 2009; Elola et al., 2007; Liu et
al., 2002) including regulation of cell-ECM adhesion (Kuwabara
and Liu, 1996) through laminin (Villa-Verde et al., 1995) and
integrins (Takenaka et al., 2004). Gal-3 is also shuttled back and
forth from the cytoplasm to the nucleus where it regulates pre-
mRNA splicing (Haudek et al., 2010). Gal-3 becomes strongly
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expressed in activated brain microglia in experimental autoimmune
disease (Reichert and Rotshenker, 1999), prion infections (Mok et
al., 2007) and after focal ischemia (Yan et al., 2009). In this study,
we investigated the potential role of Gal-3 in normal adult brain
and show that it is selectively expressed in the SVZ and RMS. By
using Gal3(Lgals3)-null mice, function-blocking antibodies and
recombinant Gal-3, we show that in contrast to Gal-1, it does not
affect neurogenesis, but specifically regulates neuronal migration,
and that loss of Gal-3 results in increased levels of phosphorylated
EGFR.
Results
Gal-3 is expressed by a subset of SVZ cells
We first investigated the distribution of Gal-3 in the adult forebrain
and found selective immunoreactivity in the SVZ and RMS (Fig.
1A). We confirmed specificity of the Gal-3 antibody by showing
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that no immunoreactivity was present in Gal3–/– mice (n6). Gal-
3 was not immunodetectable in the main OB granular and
periglomerular layers, but was expressed in the accessory olfactory
bulb (AOB) (Fig. 1A). We next determined which SVZ cell types
expressed Gal-3 (Fig. 1B). Gal-3 immunoreactivity was punctate
and diffuse. It formed a dense network surrounding clusters of
PSA-NCAM+ (polysialylated form of the neural cell adhesion
molecule) neuroblasts (Rousselot et al., 1995), but was not
expressed inside PSA-NCAM+ chains (Fig. 1C). The Gal-3
expression pattern was reminiscent of the astrocyte tubes
surrounding neuroblasts. Indeed, we found that Gal-3
immunofluorescence was associated with many glial fibrillary
acidic protein (GFAP+) SVZ astrocytes (Fig. 1D–F) and ependymal
cells lining the lateral ventricles (Fig. 1F). Adult SVZ astrocytes
and ependymal cells are derived from postnatal radial glia. Thus,
in postnatal day 7 mice, it was not surprising to find Gal-3
immunoreactivity associated with vimentin+ radial glia and
astrocytes in the SVZ and RMS (supplementary material Fig.
S1A–D). Using immunoelectron microscopy, we observed Gal-3+
immunoprecipitates in both ependymal cells and astrocytes,
confirming our previous results (Fig. 1G,H). Electron microscopy
showed Gal-3 immunoprecipitates in the cytoplasm of ependymal
cells and astrocytes, and also in the nuclei of a subset of astrocytes
(Fig. 1G,H). We continued to characterize cell subtype Gal-3
expression with confocal light microscopy and found that a subset
of Mash1+ transit-amplifying progenitor cells contained Gal-3
immunofluorescence, primarily in the cytoplasm (Fig. 1I–K).
Whereas activated CNS microglia express Gal-3 under pathological
conditions (Walther et al., 2000) and CD45+ SVZ microglial cells
are constitutively semi-activated (Goings et al., 2006), most CD45+
cells in the SVZ did not express Gal-3 (Fig. 1L–N). These results
show that Gal-3 is selectively expressed in the SVZ in astrocyte-
lineage cells and a subset of Mash1+ precursors.
Gal3-null mice exhibit distorted SVZ cytoarchitecture
We used Gal3-null mice to investigate the role of Gal-3 in the SVZ
and RMS. There was no significant change at the gross
morphological level in brain length (WT, 14.9±0.3 mm; Gal3–/–,
Fig. 1. Gal-3 expression on astrocyte lineage cells surrounds neuroblast
chains. (A)Expression of Gal-3 in the SVZ, along the RMS (arrows) and in
the accessory olfactory bulb (asterisk). Arrowhead indicates a portion of the
ventral SVZ that was included in the sagittal section. CC, corpus callosum;
CTX, cerebral cortex; LV, lateral ventricle; OB, olfactory bulb. Scale bar:
250m. (B)Cytoarchitecture of the SVZ. Astrocyte-like stem cells (‘B cells’,
green) and transit-amplifying progenitor cells (‘C cells’, blue) surround
migratory neuroblasts (‘A cells’, red). Microglia (grey) interdigitate cells and
ciliated ependymal cells (brown) line the ventricle. (C)Confocal image shows
Gal-3 (arrowhead) is not expressed by PSA-NCAM+ neuroblasts (arrow), but
Gal-3+ cells surround neuroblasts. Scale bar: 10m. (D–F) Gal-3
immunofluorescence is diffuse and is associated with some GFAP+ cells
(arrowheads). Many ependymal cells also express Gal-3 (arrow). Blue in F is
DAPI nuclear label. (G)Electron microscopy shows Gal-3 immunoreactivity
(red arrowheads) in ependymal cell (e). Note the row of cilia (black
arrowheads) on the left. Scale bar: 1m. (H)Gal-3 immunoprecipitates were
observed in astrocytes (a) (arrowheads) but not in neuroblasts (n) using
immunoelectron microscopy. Inset shows high magnification view of a Gal-3
immunoprecipitate. Scale bar: 1m. (I–K)Gal-3 (green) is expressed by few
Mash1+ cells (arrow) in the SVZ. Arrowheads indicate Mash1+ cells that are
Gal-3–. Scale bar: 10m. (L–N)Gal-3 is rarely expressed by CD45+ cells
(red). Arrow shows close juxtaposition but lack of co-labeling. Arrowhead
indicates a Gal-3+ cell that is CD45–. Scale bar: 10m.
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15.2±0.1 mm; P>0.5) or OB surface area (WT, 82,066±6239 m2;
Gal3–/–, 83,037±3780 m2, P>0.5). We also did not observe
significant differences in the structure or size of the AOB in null
mice (data not shown).
We examined the SVZ in detail and found increased GFAP
immunoreactivity throughout the SVZ (Fig. 2A–D, supplementary
material Fig. S2A–D) and RMS of Gal3–/– mice. GFAP+ cell
processes in the SVZ and RMS were distorted and appeared thicker
than in wild-type. Indeed the width of GFAP immunostaining
within astrocyte processes was significantly increased (Fig. 2E) in
the dorsal SVZ (WT, 0.62±0.05; Gal3–/–, 1.19±0.13 m; P<0.05),
middle SVZ (WT, 0.66±0.06; Gal3–/–, 1.25±0.12 m; P<0.01) and
ventral SVZ (WT, 0.6±0.1; Gal3–/–, 1.3±0.1 m; P<0.001). GFAP
immunoreactivity outside the SVZ and RMS was similar in all
groups of mice. We next used whole-mount preparations of the
lateral ventricular wall (Fig. 2F) and showed that the orientation of
GFAP+ processes was parallel to the LV wall in wild-type mice,
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but was disrupted in null mice (Fig. 2G,H). Next, we showed with
whole-mount immunohistochemistry that Dcx immunostaining was
increased in anteroventral subregions O and H (Fig. 2H) in null
mice (Fig. 2I,J). The number of Dcx+ neuroblasts migrating
individually seemed to be increased in the entire lateral ventricle
wall (Fig. 2J), suggesting that neuroblast migration was affected
by the lack of Gal-3. Although the number of individually migrating
cells appeared to be increased, the integrity of chains in Gal3–/–
mice viewed in whole mounts (Fig. 2J) and with EM, was not
altered (supplementary material Fig. S1E,F).
We examined cilia in the ependymal layer of Gal-3-knockout
(KO) mice using acetylated tubulin as a marker, and showed
remarkable loss of ciliary density (Fig. 2K,L, supplementary
material Fig. S2C–H). This was confirmed with electron
microscopy (Fig. 2M,N). Cilia are polarized to one side of
ependymal cells; however, this ependymal planar cell polarity was
not changed in null mice (supplementary material Fig. S2E,H).
These data suggest that the absence of Gal-3 disrupts several
aspects of SVZ and ependymal cell cytoarchitecture, which could
cause an impairment of normal neuroblast migration.
Gal-3 is dispensable for SVZ proliferation and cell death
Gal-3 affects cell proliferation and apoptosis in several systems
(Zhao et al., 2010). To investigate whether Gal-3 affects cell
proliferation in the SVZ, we injected a single pulse of BrdU 2
hours before sacrifice (Fig. 3A). There was no significant difference
in the number of BrdU+ cells in the SVZ between control littermates
and mutant mice (WT, 79.0±16.8; Gal3+/–, 81.9±7.6; Gal3–/–,
74.4±7.6; df11, F0.42; P>0.5) (Fig. 3B,C). Although transit-
amplifying progenitor cells are the major mitotic population in the
SVZ, astrocytes and neuroblasts also divide. To exclude the
possibility that loss of Gal-3 changed the ratio of SVZ proliferative
cell types, we used triple immunohistochemistry (Fig. 3D–F).
Proliferative astrocytes were labeled with BrdU and GFAP,
proliferative neuroblasts with BrdU and Dcx, whereas BrdU+
proliferative cells, which did not express GFAP or Dcx, were
assumed to be mainly transit-amplifying progenitors (Fig. 3G)
(Doetsch et al., 1997). The proportion of BrdU+ GFAP+ cells did
not differ significantly between wild-type (9.18±2.61%), Gal3+/–
(8.2±2.78%) and Gal3–/– (8.52±3.62%) littermates (df11, F0.108;
P>0.5) (Fig. 3G). Similarly, no significant difference was observed
in the percentage of BrdU+ Dcx+ cells (20.6±4.30% in wild-type
littermates, 19.9±1.49% in Gal3+/– and 19.15±2.56% in Gal3–/–;
df11, F0.258; P>0.5). The percentage of BrdU+ GFAP– Dcx–
cells was also unchanged in Gal3-null mice.
Galectins cause increased cell death in many cell types (Yang et
al., 1996). We first counted the number of Tunel+ cells in the SVZ
and found no differences between numbers in Gal3–/– and wild-
type mice (Fig. 3H,I) (WT, 2.85±0.51; Gal3+/–, 2.25±0.43; Gal3–/–, 
2.50±0.29; df11, F0.737; P>0.5). We next analyzed the
expression of activated (cleaved) caspase-3, a protease that is
expressed by cells undergoing apoptosis. We found no significant
change in the number of caspase-3+ cells in the SVZ (supplementary
material Fig. S3A,B) (WT, 0.46±0.096; Gal3+/–, 0.42±0.10; 
Gal3–/–, 0.41±0.095, df11, F0.75; P>0.75).
Loss of Gal-3 reduces SVZ to OB migration in vivo
Gal-3 is known to affect cell adhesion (Zhao et al., 2010) and
migration (Villa-Verde et al., 1995). To examine SVZ to OB
migration, we injected BrdU over a period of 3 days and sacrificed
mice 2 weeks after the last injection (Fig. 4A). Slowly dividing
Fig. 2. Loss of Gal-3 disrupts SVZ cytoarchitecture. (A,B)The dorsal SVZ
contains astrocytes with fine processes exhibiting moderate levels of GFAP
immunofluorescence. (C,D)Gal3-null mice had increased levels of GFAP
immunofluorescence, thickened processes, and overall distorted astrocytic
morphology in the dorsal SVZ. (A–D) Coronal sectons. Photomicrographs in
A–D were all taken with the same camera settings. Scale bar: 10m.
(E)Quantification shows significant increases in the width of GFAP+
processes in the dorsal, middle and ventral SVZ. *P<0.05; **P<0.005.
(F)Schematic showing whole-mount dissection of the lateral ventricle wall
and the subdivisions used for analysis. (G,H)Whole-mount
immunohistochemistry showed that the normal orientation of GFAP+
processes is disrupted in Gal3–/– mice. Scale bar: 20m. (I,J)Whole-mount
immunohistochemistry shows that more Dcx+ neuroblasts are migrating
individually (arrowheads) in Gal3–/– mice compared with the control. Gal3–/–
mice also had higher levels of Dcx immunofluorescence than WT in whole
mounts. Scale bars: 20m. (K,L)Loss of cilia on ependymal cells in Gal3–/–
mice is observed using anti-acetylated tubulin antibodies. Scale bar: 20m.
(M,N)Electron microscopy also shows fewer ependymal cell cilia in Gal3–/–
mice. Scale bar: 1m. All error bars represent s.e.m.
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SVZ stem cells can retain BrdU over long periods (Ferron et al.,
2007). The number of BrdU-retaining cells in the SVZ was not
altered (WT, 10.66±1.96; Gal3+/–, 11.87±1.74; Gal3–/–, 11.20±1.42,
df10, F0.44; P>0.5) by loss of Gal-3 (Fig. 4B).
To assess neuroblast migration, we counted cells in the RMS
and found significant increases in the number of BrdU+ Dcx+
cells in mutants compared with controls (WT, 1.96±0.26; 
Gal3+/–, 3.0±0.5; Gal3–/–, 2.8±0.24; df11, F8.76; P<0.01). The
number of BrdU+ cells was also significantly increased in the RMS
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of mutant compared with wild-type animals (Fig. 4C,D) (WT,
6.09±0.77; Gal3+/–, 8.92±1.27; Gal3–/–, 8.77±0.66; df11, F11.37;
P<0.005). Confirming these data, the surface area of the RMS was
significantly increased in Gal3–/– mice [WT, 16.59±0.3; Gal3+/–,
15.14±1.2; Gal3–/–, 20.35±1.3 (1000) m2; df11, F26.35;
P<0.0001] (Fig. 4E–G).
Two weeks after they are generated, most neuroblasts in the SVZ
have reached the OB where they gradually lose Dcx and express
neuronal nuclei (NeuN) as they differentiate (Fig. 5A–D) (Brown et
al., 2003). The number of BrdU+ NeuN+ cells in the granular layer
was significantly lower in Gal3–/– mice compared with wild-type
littermates (Fig. 5E) [WT, 30.2±1.8; Gal3+/–, 27.9±1.3; Gal3–/–,
23.1±1.8 (1000) mm3; df11, F19.78; P<0.001]. This finding
was corroborated by a significant overall loss of BrdU+ cells in the
granular layer of Gal3–/– mice (WT, 45±1.8; Gal3+/–, 40.5±1.6;
P<0.01; Gal3–/–, 35±1.9; df11, F32.28; P<0.0001). Changes in
the number of BrdU+ NeuN+ cells can be caused by altered rates of
differentiation. However, the ratio of BrdU+ NeuN+ to the total
number of BrdU+ cells was not different between wild-type and
mutant mice (WT, 67±1.6%; Gal3+/–, 68.9±0.6%; Gal3–/–,
65.8±2.3%; df11, F3.44; P>0.5). Qualitative analysis showed that
BrdU+ cells were evenly distributed in wild-type mice (data not
shown), whereas the majority of BrdU+ cells in the granular layer of
Gal3–/– mice were located in deep layers (Fig. 5A–D), suggesting
they had not yet migrated to superficial layers.
Fig. 3. Gal-3 does not affect SVZ proliferation or apoptosis. (A)Short-term
BrdU regimen used to assess proliferation. (B,C)The number of BrdU+ cells
in the SVZ is not different in Gal-3 mutant mice compared with WT
littermates. C shows a low magnification view of BrdU+ cells in the lateral
ventricle wall at a mid-striatal A–P level. Scale bars: 250m. (D–F) Confocal
microscopy of GFAP immunofluorescence (D), BrdU (E), and merge with
DAPI (F) from a Gal3–/– mouse. Arrow shows a BrdU+ GFAP+ cell and
arrowhead, a BrdU+ GFAP– cell. Scale bar: 10m. (G)The percentage of
BrdU+ cells that are GFAP+ or Dcx+ is not different in Gal-3 mutant mice.
(H,I)The number of Tunel+ cells in the SVZ is not altered in Gal-3 mutants.
Scale bar: 5m. Error bars represent s.e.m.
Fig. 4. Loss of Gal-3 increases the number of neuroblasts in the RMS.
(A)Long-term BrdU regimen. (B)The number of BrdU+ label-retaining cells
in the SVZ is not significantly different in Gal-3 mutants. (C)Example of
labeling for BrdU (red), Dcx (green) and DAPI (blue) in the RMS of a Gal3–/–
mouse. (D)The number of BrdU+ cells is increased in the RMS of mutants;
**P<0.005. (E,F)Dcx immunohistochemistry in the RMS of a WT and Gal3–
/– mouse. Scale bar: 100m. (G)The surface area of the RMS, measured by
outlining the perimeter of Dcx immunofluorescence, is increased in Gal3-
nulls. **P<0.0001. All error bars represent s.e.m.
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We next determined whether Gal-3 affected the number of newly
established neurons in the periglomerular layer. The number of
BrdU+ cells in this layer was dramatically decreased in mutants
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(WT, 10.3±1.3; Gal3+/–, 7.7±0.9; Gal3–/–, 2.7±0.7; df11, F60.03;
P<0.001). Similarly, the number of BrdU+ NeuN+ cells (Fig. 5F–
L) decreased greatly in nulls compared with controls (WT, 4.0±0.4;
Gal3+/–, 3.5±0.5; Gal3–/–, 1.1±0.2; df11, F54.56; P<0.001).
Tyrosine hydroxylase (TH+), calretinin (CR+), and calbindin
(CB+) interneurons in the periglomerular layer (supplementary
material Fig. S4) are preferentially derived from SVZ subregions
and sublineages (Merkle et al., 2007; Young et al., 2007). The
number of TH+ and CR+ periglomerular interneurons was
significantly decreased in mutants (Fig. 5M,N) [TH: WT, 45.8±3.6;
Gal3–/–, 22.0±1.5 (1000) cells per mm3, P<0.005; CR: WT,
116.4±8.7; Gal3–/–, 84.5±4.6 (1000) cells per mm3, P<0.05], but
the number of CB+ cells remained the same (Fig. 5O) [WT,
48.0±4.6; Gal3–/–, 42.1±3.0 (1000) cells per mm3, P>0.1].
The decreased number of newborn neurons could be due to
increased cell death; however, the number of Tunel+ cells also
decreased in mutants in the granular layer (WT, 16.3±2.0; 
Gal3+/–, 14.0±4.3; Gal3–/–, 11.7±2.3; df11, F9.1; P<0.05) (Fig.
5P,Q) and the periglomerular layer (WT, 3.3±0.9; Gal3+/–, 1.7±0.4;
Gal3–/–, 1.5±0.2; df11, F11.0; P<0.005) (Fig. 5R,S). Thus the
decrease in OB neurons was not due to increased apoptosis, but
was probably due to decreased migration.
Gal-3 modulates subcomponents of SVZ neuroblast
migration
To confirm, and examine in more detail, the role of Gal-3 on
neuroblast migration, we used two-photon time-lapse microscopy
(Nam et al., 2007). SVZ cells were labeled with intraventricular
injections of cell tracker green (CTG) (De Marchis et al., 2001)
and migration was studied 2 days later (Fig. 6A–C) (supplementary
material Movies 1 and 2). Using this strategy, we examined cells
that had migrated long distances from the SVZ to the RMS. Wild-
type neuroblasts migrated at an average speed of 106±7 m/hour,
which was similar to results of our previous studies (Kim et al.,
2009; Nam et al., 2007). Neuroblasts moved significantly slower
in mutants (Gal3–/–, 84±3 m/hour; P<0.05) (Fig. 6D), primarily
as a result of decreased time spent in the fast phases of movement
(WT, 13.6±2.8%; Gal3–/–, 4.9±1%; P<0.05) (Fig. 6E). We next
measured a parameter that is independent of speed, the migratory
index (net distance over total distance). It was significantly
decreased (WT, 0.61±0.01; Gal3–/–, 0.48±0.03; P<0.01) (Fig. 6F),
indicating that the Gal3–/– cells moved in a more complex local
manner. Confirming this result, the net distance moved by
neuroblasts in mutant mice decreased (Fig. 6G). These differences
in motility subcomponents can be readily seen when the cell
pathways are traced and shown in three dimensions (Fig. 6H,I). We
also counted the percent cells exhibiting motility and showed there
was no difference between groups of mice.
Secreted Gal-3 modulates migration from explants
The studies above could not distinguish whether secreted Gal-3 is
sufficient to regulate neuroblast migration. To directly test this, we
cultured RMS explants in the presence of either a blocking antibody
specific for Gal-3 (clone M3/3828) (Inohara and Raz, 1995) or
mouse recombinant rGal-3. We used postnatal day 4 mice because
explant migration is more robust at this age (Ward and Rao, 2005)
and we knew that Gal-3 is expressed in radial glia as well as
astrocytes at this stage. The RMS was initially dissected from the
OB core of Dcx–GFP mice (Fig. 7A), to confirm the identity of
migrating cells. Only Dcx-GFP+ neuroblasts emigrated from the
cultured explants (data not shown). Anti-Gal-3 blocking antibody
Fig. 5. Gal3-null mice have fewer new OB neurons. (A–D) Examples of
BrdU and NeuN immunoreactivity in the OB granular layer of Gal3–/– mice.
Note that most BrdU+ NeuN+ cells are in the deep granular layer near the
RMS. (ipl, internal plexiform layer). Inset shows a double-labeled cell
(yellow) at higher magnification. Scale bar: 50m. (E)The number of BrdU+
NeuN+ cells is significantly decreased in the granular layer of Gal3–/– mice.
**P<0.001. (F–H) BrdU+ NeuN+ cells in the periglomerular layer of the OB
of a WT mouse. Scale bar: 10m. (I–K) BrdU+ NeuN+ cells in the
periglomerular layer of the OB of Gal3–/– mice. Scale bar: 10m. (L)The
number of BrdU+ NeuN+ cells is significantly decreased in the periglomerular
layer of Gal3–/– mice. **P<0.001. (M–O) The number of TH+ and CR+, but
not CB+, cells decreases significantly in the OB of Gal3–/– mice. *P<0.05,
**P<0.005. (P,Q)The number of Tunel+ cells is significantly decreased in the
OB granular layer. Arrows indicate a typical Tunel+ cell. Scale bar: 10m.
*P<0.05. (R,S)The number of Tunel+ cells is significantly decreased in the
OB periglomerular layer. Arrows indicate a typical Tunel+ cell. Scale bar:
10m. **P<0.005. All error bars represent s.e.m.
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inhibited neuroblast migration after 48 hours in a dose-dependent
manner, whereas control IgG had no effect on the average distance
migrated (Ctl, 222±5; Ctl IgG, 212±14; 0.5 g/ml Gal-3 antibody,
193±9; 2.0 g/ml, 98±5; 5.0 g/ml, 7±1; df59, F1.553;
P<0.0005) (Fig. 7B–D). These results were confirmed with time-
lapse microscopy (supplementary material Movie 3). Indeed,
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migration from explants was delayed and severely reduced in the
presence of 2.0 g/ml of anti-Gal-3 after 4 hours (supplementary
material Movie 3). In contrast to the function blocking antibody,
rGal-3 significantly increased migration in a dose-dependent fashion
(Fig. 7E–G) (Ctl, 282±11; 0.3 g/ml rGal-3, 337±12; 3 g/ml,
327±8; 10 g/ml, 345±7; df47, F229.7; P<0.001).
We next examined whether anti-Gal-3 antibodies affected chain
migration. Both the number of neuroblast chains (Fig. 7H–J), as
well as the percentage of cells migrating in chains (Fig. 7I), was
Fig. 6. Two-photon time-lapse microscopy reveals slower and more
complex motility in Gal3 null mice. (A)Cell tracker green was injected into
the lateral ventricle and 2 days later neuroblast migration was analyzed at the
RMS elbow in slices. Low-magnification photomicrograph on right shows
CTG-labeled cells migrating in the RMS. (B)Still images from a two-photon
time-lapse movie from a WT slice (supplementary material Movie 1). Colored
arrows show the positions of two CTG-labeled neuroblasts. Time stamps are in
hours:minutes. (C)Still images showing the positions of two CTG-labeled
neuroblasts (colored arrows) in a Gal3–/– slice (supplementary material Movie
2). Scale bar: 50m. (D)Speed of migration is decreased in null mice
compared with the WT. *P<0.05. (E)The percentage of migrating cells in the
fast migratory phase is significantly decreased in null mice compared with the
WT. *P<0.05. (F)The migratory index (net distance divided by total distance)
is decreased in null mice compared with the WT. *P<0.05. (G)The net
distance of migrating neurons is decreased in null mice compared with the
WT. *P<0.01. (H,I)Tracks of individual neuroblast migration in WT and
Gal3-null mice showing that null mouse neuroblasts exhibit decreased
motility. Each color represents the path of a different cell. All error bars
represent s.e.m.
Fig. 7. Soluble Gal-3 increases SVZ neuroblast migration from explants.
(A)Explants taken from the rostral part of the RMS of P4 Dcx–GFP mice and
cultured in Matrigel for 48 hours show robust migration. (B)Gal-3 function-
blocking antibody inhibits migration. Concentration of antibodies was
ing/ml. (C,D)Compared to IgG control, migration is blocked in 5.0g/ml
anti-Gal-3. (E,F)Neuroblast migration increases in the presence of
recombinant Gal-3. (G–I) The number of neuroblast chains and percentage of
cells migrating in chains decreases after anti-Gal-3 treatment. (Error bars in H
too small to be visible. All error bars represent s.e.m.) *P<0.05, **P<0.005.
Scale bars:100m. (J)Examples of chain migration (arrow) from control
explants (exp) and individual cell migration (arrowhead) in anti-Gal-3
antibody treated explants. Frames taken from supplementary material Movie 3,
time-stamps indicate minutes after plating of explant.
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significantly reduced with 2 g/ml of anti-Gal-3. The number of
chains was maximally decreased 6 hours after treatment (22.3±1.2
versus 6.7±0.3, P<0.05). At 6 hours, the percentage of cells in
chains was decreased from 48.8±6.6% in controls to 24.5±2.0%
(P<0.05). These observations suggest that secreted Gal-3 modulates
various aspects of neuroblast migration in vitro.
Reduced expression of phosphorylated EGFR in Gal3–/–
mice
Gal-3 physically interacts with the EGFR (Partridge et al., 2004)
and activation of EGFR decreases neuronal migration (Kim et al.,
2009). To test whether Gal-3 regulates EFGR expression, we
performed western blots using an antibody specific for EGFR (n3
experiments). No difference in EGFR expression was observed in
Gal3–/– mice compared with wild-type SVZs (Fig. 8A,B). EGFR
phosphorylation is necessary for its activation; interestingly,
phosphorylated EGFR was significantly increased in Gal3–/–
compared with wild-type SVZs (Fig. 8A,B) (P<0.05) (n3
experiments). These results suggest that Gal-3 either directly or
indirectly inhibits EGFR phosphorylation. However, co-
immunoprecipitation assays (n3 experiments) revealed that in the
SVZ, Gal-3 does not bind to EGFR (data not shown).
Discussion
Although the function of Gal-3 has been extensively studied in the
regulation of inflammation and cancer, its role in the normal brain
was unknown. This study shows that Gal-3 is constitutively
expressed in the adult SVZ and along the normal route of neuroblast
migration. In addition, we provide evidence that secreted Gal-3, by
maintaining the niche cytoarchitecture, modulates neuroblast
migratory behavior without affecting SVZ proliferation or
apoptosis. Although Gal-3 is known to influence migration in other
cell types, to our knowledge this is the first evidence that it
modulates neuronal migration.
Galectin-3 maintains SVZ and RMS cytoarchitecture
It was previously known that in the context of brain injury and
other pathological conditions, Gal-3 becomes expressed by
activated microglia. However, its expression in normal brain had
never been reported. In this study, immunohistochemistry showed
selective Gal-3 expression in the SVZ and RMS, which are areas
that exhibit the most extensive neurogenesis and migration in adult
brains. These results are supported by the localization of Gal3
transcripts in the SVZ and RMS (Ng et al., 2009). We hypothesized
that microglia, which are constitutively semi-activated in the SVZ,
are the cells that express Gal-3 in this region. However, SVZ
microglia were only weakly associated with Gal-3 expression,
suggesting that neural rather than hematopoietic cells express it.
Indeed, Gal-3 immunoreactivity was associated with astrocyte
and ependymal cells. Because ependymal cells and astrocytes
lining the lateral ventricles arise from radial glia (Spassky et al.,
2005; Tramontin et al., 2003), it was not surprising that postnatal
SVZ radial glia also expressed Gal-3. Our EM studies showed that
both astrocyte and ependymal cell cytoplasm contained Gal-3
immunoprecipitates. A subset of astrocyte nuclei also contained
Gal-3 immunoprecipitates. Nuclear Gal-3 participates in splicing
of pre-mRNA (Haudek et al., 2010), and it is tempting to speculate
that its differential cell compartment expression in the SVZ might
underlie some of the differences between SVZ astrocytes and
ependymal cells. A recent study using human GFAP–GFP and
prominin labeling to isolate SVZ stem cells shows they exhibit
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high levels of Gal-3 (Beckervordersandforth et al., 2010). Future
FACsorting approaches might confirm SVZ cell subtype expression
of Gal-3 (Pastrana et al., 2009). Interestingly, although Gal-3
expression lined the migratory route, both light and electron
microscopy showed that it was not expressed by neuroblasts
themselves. Our current data support the notion that Gal-3 is
expressed in the SVZ and RMS by SVZ astrocytes and ependymal
cells, but is lost in most of their progeny. These observations
suggest that Gal-3 is well positioned to regulate the SVZ niche.
Because Gal-3 was expressed by both astrocytes and ependymal
cells, it was not altogether surprising to find that loss of Gal-3
resulted in abnormal astrocytic and ependymal cytoarchitecture in
the SVZ. Astrocytes had thickened GFAP immunoreactivity within
their processes and distorted morphology throughout the SVZ and
RMS. GFAP is an intermediate filament cytoskeletal protein and
antibodies against it do not reveal astrocyte plasma membranes.
Although we do not believe it is likely, it is possible that widths of
GFAP immunoreactivity increased without the entire process
thickening. Gal-3 promotes process outgrowth in dorsal root
ganglion neurons (Pesheva et al., 1998) and axonal branching in
hippocampal neurons (Diez-Revuelta et al., 2010), suggesting that
it regulates morphology in a variety of neural cells. Disrupted SVZ
and RMS astrocytic cytoarchitecture has been associated with
abnormal migration in Bax-null mice (Kim et al., 2007) and ErbB4
mutants (Ghashghaei et al., 2006).
Another cellular mechanism that might influence SVZ neuroblast
migration is the beating of ependymal cell cilia, which establishes
gradients of chemorepellents in the SVZ (Sawamoto et al., 2006).
We found a marked decrease in the density of ependymal cilia,
suggesting that CSF flow is disrupted in Gal3-null mice. These
results suggests that Gal-3 might have a role in forming and
maintaining SVZ niche cytoarchitecture and influences neuroblast
migration by a combination of maintaining astrocyte glial tubes
and ciliary integrity.
Gal-3 maintains normal SVZ neuroblast migration
Gal-3 is known to influence proliferation of endometrial cells (Lei
et al., 2009) and preadipocytes (Kiwaki et al., 2007) by inhibiting
and stimulating cell division, respectively. Gal-1 is also expressed
by SVZ astrocytes and promotes cell proliferation (Sakaguchi et
Fig. 8. Phosphorylated EGFR expression is increased in the SVZ of 
Gal3–/– mice. (A,B)Western blots and quantification show that basal levels of
EGFR are unchanged in mutant mice. By contrast, phosphorylated EGFR is
significantly upregulated in Gal3–/– mice.
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al., 2006). Thus, we hypothesized that Gal-3 influences cell
proliferation in the adult SVZ; however, basal rates of proliferation
were unchanged. SVZ stem cells self-renew with infrequent
mitoses, and similarly to more rapidly dividing cells, there was no
change in the number of label-retaining cells. Thus Gal-3 does not
seem to affect multiple types of cell proliferation in the adult SVZ.
Apart from its proliferative role, Gal-3 is also known to act as
an adhesion and de-adhesion molecule (Friedrichs et al., 2008) and
its pattern of expression in the SVZ led us to study neuroblast
migration. Furthermore, Gal-3 binds -galactoside residues on
EGFR, laminin, 1 integrin, NCAM and tenascin, all of which
influence SVZ neuroblast migration (Aguirre et al., 2005; Cremer
et al., 1994; Emsley and Hagg, 2003; Ghashghaei et al., 2007; Kim
et al., 2009). We found significantly fewer newborn neurons in the
periglomerular and granule layers of the OB in Gal3-null mice 2
weeks after BrdU administration, suggesting decreased migration.
In addition, the RMS size and number of newborn neurons in the
RMS of Gal3-null mice was increased 2 weeks after BrdU injection.
This might reflect cell accumulation due to inefficient migration.
The greater RMS size might also have been partially caused by
increased thickness of GFAP+ astrocytic processes. Although SVZ
apoptosis did not seem to change in the Gal3-null mice, decreased
numbers of Tunel+ cells in the OB of these mice were observed
and could be explained by lower rates of neurons reaching the OB
and then undergoing apoptosis. Taken together, the in vivo data
suggest that in the absence of Gal-3, SVZ cell migration is
disrupted.
Although our in vivo studies strongly suggested that Gal-3
maintains migration, lack of Gal-3 did not completely stop
migration because the OB size in mutant was unchanged. We used
two-photon time-lapse microscopy to image migration at a finer
spatiotemporal scale and dissect which aspects of migration might
have been affected by Gal-3. We chose the RMS because all SVZ
cells funnel through it before reaching the OB and because in vivo
evidence suggested decreased RMS migration in Gal3-null animals.
Two-photon time-lapse imaging previously revealed that only a
subset of neuroblasts are migratory at any time and that they
migrate in multiple directions, at different speeds and in long
distance rostral and local exploratory patterns (Nam et al., 2007).
Importantly, CTG-labeled neuroblasts in wild-type mice in this
study moved at very similar speeds to migratory GAD–GFP+ cells
in our previous study (Nam et al., 2007), suggesting that CTG did
not alter migration. Neuroblasts in Gal3-null mice migrated more
slowly and exhibited more exploratory motility. They moved shorter
net distances, corroborating the increases in exploratory motility.
These direct observations provide compelling evidence that Gal-3
maintains speed and straightness of migration, two parameters that
synergize efficient rostral migration. Taken together, we interpret
our data to suggest that decreasing these specific components of
migration is sufficient to significantly delay migration and thereby
decrease rates of OB neurogenesis.
Secreted Gal-3 promotes neuroblast migration
Gal-3 has cell-autonomous effects, as well as cell surface and
secreted paracrine effects (Ochieng et al., 2004). Therefore we
used acute in vitro RMS explants from wild-type mice to examine
the role of secreted Gal-3 in migration. Previously validated anti-
Gal-3 functional blocking antibodies (Fukushi et al., 2004)
decreased neuroblast migration dose-dependently, whereas control
IgG antibodies did not. It is possible that the anti-Gal-3 antibodies
decreased migration through a simple steric hindrance mechanism
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rather than by decreasing Gal-3 function. However, our function-
blocking antibody studies matched the decreased migration in
Gal3–/– slices and in vivo, and the control IgG antibody had no
effect on migration. In contrast to anti-Gal-3, recombinant Gal-3
increased migration distances. Thus, these studies confirmed that
Gal-3 directly and acutely affects SVZ migration, adding credence
to our in vivo and slice data from the mutant mice.
We also showed that loss of Gal-3 function decreases chain
formation in vitro; the number of chains and the percentage of cells
migrating in chains decreased dramatically in response to the
blocking antibody. In addition, our in vivo analysis suggested that
the number of neuroblasts migrating individually was increased in
Gal3–/– mice. Thus, secreted Gal-3 might contribute to chain
formation and maintenance.
Gal-3 might affect migration via the EGFR
Epidermal growth factor drives proliferation in the SVZ (Kuhn et
al., 1997; Reynolds and Weiss, 1992) and helps maintain its balance
of stem and progenitor cells (Doetsch et al., 2002). We recently
showed that a subset of SVZ neuroblasts retains EGFR expression,
EGFR+ neuroblasts moved more slowly and in a more exploratory
manner, and when EGFR was stimulated, the percentage of
migrating neuroblasts decreased (Kim et al., 2009). Thus it seems
that EGFR signalling also mediates major transitions in the SVZ
by pushing cells backwards to a non-migratory phenotype. We
show in this study that, similar to EGFR+ neuroblasts, loss of Gal-
3 decreased speed and increased migration complexity. This was
accompanied by increases in phosphorylated EGFR (active form)
in Gal3–/– mice. Such an interaction has been recently described in
pancreatic cancer cells: knockdown of Gal-3 increases
phosphorylated EGFR (Merlin et al., 2011). Gal-3 interacts with
glycoproteins such as the EGFR (Partridge et al., 2004) and the
neuronal adhesion molecule L1 (Diez-Revuelta et al., 2010),
proteins that regulate neuronal migration. Gal-3 is thought to
crosslink EGFR, stabilize them and reduce endocytosis (Partridge
et al., 2004). In this study, using co-immunoprecipitation we did
not detect physical binding between Gal-3 and EGFR. Overall, our
results suggest that loss of Gal-3 decreases SVZ neuroblast
migration by indirectly increasing EGFR activation in neuroblasts.
Conclusion
Galectins have important actions in pathological inflammation
(Sato and Nieminen, 2004) and cancer, but their potential function
in normal neurodevelopmental processes has been under-explored.
In this study, we show that Gal-3 is necessary for normal SVZ
migration. Carbohydrates are essential for neural development,
and glycoconjugates seem to be particularly important in the
modulation of SVZ migration (Ono et al., 1994). This study expands
our understanding of the promigratory niche by introducing a
sugar-binding molecule as a modulator of important neuroblast
migration parameters and might lead to the development of new
strategies designed to allow neuroblast migration to human brain
damage.
Materials and Methods
Animal use
P4 and adult (6–8 week) CD1 mice were obtained from Charles River Laboratories
(Margate, UK), adult wild-type, Gal3+/– and Gal3–/– littermates on 129Sv background
from Francoise Poirier (Colnot et al., 1998). Doublecortin–GFP mice were generated
at the Gensat BAC project at Rockefeller University. All procedures were carried out
with Oxford University Research Ethics Committee approval, in accordance with the
Animals (Scientific Procedures) Act of 1986 (UK). All efforts were made to minimize
animal suffering and distress.
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Bromodeoxyuridine injections
To examine proliferation, a cohort of mice received one injection of 50 mg/kg
bromodeoxyuridine (BrdU) (Sigma) i.p., 2 hours before perfusion and sacrifice (n4
for WT, Gal3+/–, Gal3–/–). To examine migration, another cohort received three
injections of BrdU (50 mg/kg, i.p.) per day for 3 days and were sacrificed 2 weeks
after the last injection (n4 for WT, Gal3+/–, Gal3–/–).
Immunohistochemistry
Immunohistochemical detection of BrdU and proteins was carried as described
previously (Kim et al., 2010). We used the following primary antibodies: mouse anti-
acetylated tubulin (1:1000; Sigma), rabbit anti--catenin (1:1000; Sigma), goat anti-
CD45 (1:500; Santa Cruz Biotechnology, Santa Cruz, USA), mouse anti-Mash1
(1:500; Pharmingen), rabbit anti-Gal-3 (1:100; Santa Cruz Biotechnology), goat
anti-GFAP (1:500; Santa Cruz Biotechnology), mouse anti-PSA-NCAM (1:500;
Chemicon, Temecula, CA), mouse anti-NeuN (1:500; Chemicon), goat anti-vimentin
(1:100; Santa Cruz Biotechnology), rabbit anti-tyrosine hydroxylase (1:2000;
Chemicon), rabbit anti-calretinin (1:2000; Chemicon) and rabbit anti-calbindin
(1:500; Chemicon). The secondary antibodies used were conjugated to Streptavidin
Alexa Fluor 546 (1:500, Invitrogen, Paisley, UK), Alexa Fluor 488 (1:500; Invitrogen)
or Cy3 (1:500; Jackson ImmunoResearch). We routinely checked for aberrant
background staining of secondary antibodies by omitting the primary antibodies.
All BrdU-positive cells along the wall of the lateral ventricle and RMS were
counted in at least ten evenly spaced sections per animal, from coordinates –0.40 to
1.33 relative to Bregma using a 40 lens. BrdU+ NeuN+ TH+ CB+ CR+, cells were
counted in at least ten evenly spaced sections of olfactory bulb per animal at 40
using confocal microscopy, in five optical sections separated by 2 m each. The total
number of cells per mm3 was calculated. The total number of BrdU+ TH+, BrdU+
CB+ and BrdU+ CR+ cells present in the entire periglomerular layer of ten evenly
spaced olfactory bulb sections per animal was counting using a confocal microscope.
Investigators were blind to the genotype for all quantifications.
TUNEL labeling
Sections were rinsed twice in Tris-buffered saline (TBS), dehydrated and rehydrated
in graded isopropanol, rinsed twice in TBS, and pre-incubated with terminal
transferase (TdT) buffer (Roche) for 15 minutes at 37°C. Positive control sections
were treated with 2 mg/ml DNase (Sigma) for 15 minutes. Subsequently, sections
were incubated in TdT mixture (Roche) for 30 minutes at 37°C, rinsed three times
in TBS. Six evenly spaced sections per animal were analyzed from Bregma +1.2 to
–0.5 in the SVZ and Bregma +3.8 to +5.8 in the OB (n4 WT, n4 Gal3–/–). The
total number of positive cells per section in the SVZ, OB periglomerular and
granular layer, was counted with the investigator blind to genotype.
Whole mounts
Dissection of the lateral wall and immunostaining were performed as previously
described (Mirzadeh et al., 2008) on n3 WT and n3 Gal3–/– mice.
Immunoelectron microscopy
The experiment was performed as previously described (Moss and Bolam, 2008) on
n3 WT and n3 Gal3–/– mice.
Image acquisition
Epifluorescent microscopy images were obtained on a Leica DMIRB with a digital
camera (Hamamatsu C4742-95) and analyzed with Openlab 5. Colocalization studies
were carried out using confocal microscopy (Zeiss LSM 710). Optical sections
(Z0.5 m) were sequentially acquired using a 63 oil objective lens and Zeiss
LSM image 5 software used to merge images.
Two-photon time-lapse microscopy
10 mM cell tracker green (CTG) (CMFDA, Molecular Probes) in DMSO was
injected into lateral ventricle as previously described (Kim et al., 2009) (stereotactic
coordinates A-P 0.1, M-L 0.70, D–V 2.5 from bregma for WT; A–P 0.15, M–L 0.70,
D–V 2.5 for Gal3–/–). Migration was imaged 2 days later. Brains were submerged in
ice-cold artificial cerebrospinal fluid (aCSF; 125 mM NaCl, 2.5 mM KCl, 2 mM,
CaCl2, 1 mM MgCl2, 26 mM NaHCO3, 1.25 mM H2PO4, and 25 mM glucose at pH
7.4) and 300 m sagittal slices cut on a Vibratome (Campden Instruments). Brain
slices were treated as previously described (Nam et al., 2007). A custom-built two-
photon imaging system (Nam et al., 2007) was used to acquire a stack of 51 optical
sections (separated by 1 m) every 3 minutes. Oxygenated aCSF was continuously
perfused throughout imaging at 0.5–1.0 ml/minute.
Two-photon time-lapse analysis
Two-photon images were acquired by Fluoview software (Olympus) and imported
into Volocity software (Improvision) for processing and quantification. Collapsed
stacks of 3D images were exported into Quicktime (Apple) to generate 2D time-lapse
movies. For quantifying percentage of motile cells, cells that moved over two cell
diameters were numbered and traced over the first 1 hour. Then, 3D coordinates of
cells were recorded over the first 1 hour period. Only cells that were traceable for the
entire hour were included in speed and migratory index analysis. A random number
generator randomly selected ten such cells. Any slice drifting was adjusted by aligning
stationary cells across frames. Total distance was defined as the sum of all frame-to-
frame cell movements from a given cell’s trajectory, and net distance was defined as
the distance between the initial and final cell positions. Migratory index was defined
as the net distance divided by total distance. If the migratory index was less than 0.4,
between 0.4 and 0.6, or more than 0.6, cells were classified as exploratory, intermediate,
or migratory, respectively. For speed analysis, if cells moved from frame to frame less
than 100 m/hour, between 100 and 200 m/hour, or more than 200 m/hour, each
movement was categorized as slow, intermediate, and fast respectively.
Explant culture and time-lapse microscopy
Explants were prepared as previously described (Ward and Rao, 2005). These
explants were embedded in 33% Matrigel (BD Biosciences, San Jose, CA)
supplemented with 2.5 mg/ml collagen type I (BD Biosciences) and kept for 48
hours at 37°C and 5% CO2. Explants were cultured in DMEM with 10% fetal bovine
serum, penicillin-streptomycin, with anti-mouse Gal-3 function-blocking rat
monoclonal antibody (clone M3/38; Santa Cruz Biotechnology) or control rat IgG
(Santa Cruz Biotechnology). Alternatively, explants were incubated with mouse
recombinant Gal-3 (R&D systems, Minneapolis, MN) or equivalent volumes of
solvent (PBS+ 0.1% BSA). For time-lapse, explants were cultured in humidified
chambers at 37°C and aerated with 5% CO2. Pictures were taken every 6 minutes
using a digital camera (Hamamatsu C4742-95, Shizouka, Japan) and a Leica DMIRB
inverted microscope and analyzed with Openlab 5 software (Improvision, Coventry,
UK). Cell migration was first analyzed in explants from Dcx–GFP mice to confirm
the neuroblast identity of migrating cells (n20 explants). Quantification of cell
migration was then performed on explants from CD-1 mice (at least 50 explants for
each condition). Migration distances were measured on 10 digitized images as the
distance between the edge of the explant and the farthest cells. Eight measurements
per explant were performed covering the totality of the area of migration using
Openlab 5. To study chain migration from the explants, image frames were analyzed
at 120, 240 and 360 minutes. ‘Chains’ were defined as clusters of at least three
contiguous cells. The percentage of cells emigrating in chains was determined as the
ratio of cells in chains over the total number of cells having emigrated from the
explant (n3 explants for each condition).
Western blot and densitometric analysis
SVZ tissue from WT and Gal3–/– mice were homogenized in lysis buffer (0.025M
Tris-HCl, 0.15 M NaCl, 0.001 M EDTA, 1% NP-40, 5% glycerol; pH 7.4). Proteins
were separated by SDS-PAGE under reducing conditions and transferred to
nitrocellulose membranes. Membranes were blocked with 5% skimmed milk in TBS
at room temperature for 1 hour. Membranes were then incubated with either anti-
EGFR (1:500; Sigma), anti-pEGFR Tyr1173 (1:1000; Millipore) or anti-beta-actin
(1:200; Sigma) overnight at 4°C. Membranes were next incubated with HRP-
conjugated secondary IgGs (1:500) for 1 hour. All membranes were visualized using
luminol reagent (Bio-Rad). Densitometric analysis of the membrane was performed
using a Model imaging densitometer (Bio-Rad) in transmittance mode and analyzed
using ImageJ software.
Statistics
Data are presented as mean ± s.e.m. Differences between two different groups were
assessed using two-tailed Student’s t-test and differences amongst three or more
groups with one-way ANOVA. Groups were considered significantly different when
at least a 95% confidence level (P<0.05) was obtained.
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